167 related articles for article (PubMed ID: 1859238)
1. [Transitory acute kidney insufficiency and insulin-dependent after treatment of kala-azar with pentamidine and N-methylglucamine antimony].
Morin D; Dumas ML; Valette H; Dumas R
Arch Fr Pediatr; 1991 May; 48(5):349-51. PubMed ID: 1859238
[TBL] [Abstract][Full Text] [Related]
2. [Agranulocytosis caused by glucantime (N-methylglucamine antimoniate) during treatment of kala-azar].
Gutiérrez Rodero F; Moya Jeromini I; Ortiz de la Tabla Ducasse V; Pozuelo González A
Med Clin (Barc); 1985 May; 84(20):840. PubMed ID: 4033266
[No Abstract] [Full Text] [Related]
3. Treatment of kala azar.
Ozsoylu S
Lancet; 1996 Jun; 347(9016):1701. PubMed ID: 8642997
[No Abstract] [Full Text] [Related]
4. [Nephrotic syndrome and acute pancreatitis related to glucantime administration].
Valencia ME; Laguna F; González Lahoz J
An Med Interna; 2000 Jan; 17(1):54. PubMed ID: 10730416
[No Abstract] [Full Text] [Related]
5. [Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases].
Bourée P; Anciaux ML; Taugourdeau P
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):607-10. PubMed ID: 3003657
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of visceral leishmaniasis or kala-azar (author's transl)].
Laroche R; Sirol J; Poli L
Med Trop (Mars); 1978; 38(4):401-4. PubMed ID: 215868
[No Abstract] [Full Text] [Related]
7. Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis.
Andersen EM; Cruz-Saldarriaga M; Llanos-Cuentas A; Luz-Cjuno M; Echevarria J; Miranda-Verastegui C; Colina O; Berman JD
Am J Trop Med Hyg; 2005 Feb; 72(2):133-7. PubMed ID: 15741547
[TBL] [Abstract][Full Text] [Related]
8. Antimony containing drug and ECG abnormalities in children with visceral leishmaniasis.
Zanoni LZ; Brustoloni YM; Melnikov P; Cônsolo CE
Biol Trace Elem Res; 2009 Dec; 132(1-3):35-40. PubMed ID: 19424667
[TBL] [Abstract][Full Text] [Related]
9. Treatment of kala-azar in India.
Thakur CP
Natl Med J India; 1992; 5(5):203-5. PubMed ID: 1338871
[No Abstract] [Full Text] [Related]
10. Cytogenetic observations after meglumine antimoniate therapy for visceral leishmaniasis.
Hantson P; Léonard ED; Crutzen-Fayt MC; Léonard A; Vandercam B; Delaere B; Mahieu P
Pharmacotherapy; 1996; 16(5):869-71. PubMed ID: 8888081
[TBL] [Abstract][Full Text] [Related]
11. Acute pancreatitis associated with the administration of meglumine antimonate for the treatment of visceral leishmaniasis.
de Lalla F; Pellizzer G; Gradoni L; Vespignani M; Franzetti M; Stecca C
Clin Infect Dis; 1993 May; 16(5):730-1. PubMed ID: 8507769
[No Abstract] [Full Text] [Related]
12. [Agranulocytosis caused by glucantime in the treatment of kala-azar].
Gutiérrez Rodero F
Med Clin (Barc); 1986 Mar; 86(10):437. PubMed ID: 3713304
[No Abstract] [Full Text] [Related]
13. Kala-azar in Afghanistan.
Singh M; Arya LS; Aram GN; Fazal MI; Qureshi MA; Goel RG
J Trop Med Hyg; 1982 Oct; 85(5):201-4. PubMed ID: 7176002
[TBL] [Abstract][Full Text] [Related]
14. Severe adverse reactions to meglumine antimoniate in the treatment of visceral leishmaniasis: a report of 13 cases in the southwestern region of Brazil.
Oliveira AL; Brustoloni YM; Fernandes TD; Dorval ME; Cunha RV; Bóia MN
Trop Doct; 2009 Jul; 39(3):180-2. PubMed ID: 19535762
[TBL] [Abstract][Full Text] [Related]
15. Meglumine antimoniate-induced pancreatitis.
Torrús D; Massa B; Boix V; Portilla J; Pérez-Mateo M
Am J Gastroenterol; 1996 Apr; 91(4):820-1. PubMed ID: 8677970
[No Abstract] [Full Text] [Related]
16. [N-methyl glucamine antimoniate or Glucantime].
Rapp C; Simon F; Dordain ML
Med Trop (Mars); 2000; 60(4):342-3. PubMed ID: 11436584
[No Abstract] [Full Text] [Related]
17. Severe leucopenia during treatment of visceral leishmaniasis.
Hiçsönmez G; Jama H; Ozsoylu S
Trans R Soc Trop Med Hyg; 1988; 82(3):417. PubMed ID: 3232176
[No Abstract] [Full Text] [Related]
18. Problems in the treatment of kala-azar: case report.
Nyakundi PM; Rashid JR; Wasunna KM; Were JB; Muigai R; Kirigi G; Mbugua J
East Afr Med J; 1995 Jun; 72(6):406-8. PubMed ID: 7498017
[TBL] [Abstract][Full Text] [Related]
19. Visceral leishmaniasis and disseminated intravascular coagulation in a dog.
Font A; Gines C; Closa JM; Mascort J
J Am Vet Med Assoc; 1994 Apr; 204(7):1043-4. PubMed ID: 8045804
[TBL] [Abstract][Full Text] [Related]
20. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
